Search

A study conducted at the University of Malaysia Terengganu focused on the transmission dynamics of rabies in the dog population, highlighting the importance of vaccination in preventing the spread of the disease. The research emphasized the role of mathematical models in predicting and controlling rabies outbreaks, with a particular focus on the effectiveness of vaccination strategies. The study concluded that a high vaccination rate is crucial for effectively controlling rabies, especially in regions where the disease poses a significant threat to public health, such as Africa and Asia. [Extracted from the article]

A recent study conducted by Debre Markos University in Ethiopia focused on the incidence of suspected human rabies virus exposure and associated risk factors in the country. The research highlighted that rabies disproportionately affects Asia and Africa, causing significant mortality and economic losses annually. The study found that the pooled incidence rate of suspected human rabies virus exposure in Ethiopia was 54.03 per 100,000 population, with variations observed by region and a significant association with gender. The researchers emphasized the importance of prevention strategies such as dog vaccination, public awareness, and improved surveillance systems to address human rabies virus exposure. [Extracted from the article]

Researchers from the University of Georgia have conducted a study on the molecular epidemiology, evolution, and transmission dynamics of raccoon rabies virus in Connecticut. The study aimed to investigate the source-sink dynamics of the virus, the impact of natural barriers on transmission, and the genomic diversity and transmission dynamics in the state. The findings suggest the presence of spatial structuring in the phylogenetic trees and highlight the importance of targeted control programs, vaccination efforts, and enhanced surveillance at borders to curb the spread of the virus. This research provides valuable insights for public health officials and policymakers in managing rabies outbreaks effectively. [Extracted from the article]

A study conducted in the Amhara region of Ethiopia focused on the demography and ecology of owned dogs in relation to rabies. The research found that there was a low dog population relative to humans, but most dogs were not properly managed, with low rates of confinement and vaccination. The study highlighted the importance of raising awareness about responsible dog ownership to reduce the risk of zoonotic diseases like rabies. The findings provide valuable information for developing effective rabies control strategies, although the study did not include stray dogs, which play a significant role in the spread of rabies. [Extracted from the article]

Researchers at the National Institutes for Food and Drug Control in Beijing, China, have conducted a study on the Vero cell rabies vaccine, which is widely used for human rabies prevention. The study focused on evaluating the vaccine production process to remove residual host cell DNA (HCD) from the final product. The research found that the production process effectively recovered viral antigens and efficiently removed residual HCD, meeting WHO recommendations and Chinese Pharmacopeia requirements. The study provides guidance for optimizing vaccine production processes and ensuring safety and efficacy in large-scale batch production. [Extracted from the article]

The article discusses the impact of mutations in the rabies glycoprotein (G) on the effectiveness of antibodies used for post-exposure prophylaxis. Through deep mutational scanning, researchers identified critical sites on the G protein and mapped escape mutations for various antibodies. This information can guide the development of stable vaccine antigens and antibodies that can withstand genetic variations in rabies strains. The study provides valuable insights into the functional and antigenic effects of G mutations, aiming to improve rabies prevention strategies. [Extracted from the article]

Researchers at the University of Pennsylvania School of Engineering have developed a method to modify lipid nanoparticles (LNPs) to target specific cells, including neurons, and cross the blood-brain barrier. This advancement could lead to potential treatments for neurological diseases like Alzheimer's and Parkinson's. By using peptides as targeting molecules, the LNPs can deliver mRNA to the brain's endothelial cells and neurons, a crucial step in developing mRNA-based treatments for brain diseases. The study was supported by various organizations, including the U.S. National Institutes of Health and the American Cancer Society. [Extracted from the article]

A study conducted by the University of Oxford in Burkina Faso evaluated the safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in children aged 5-17 months. The trial showed that the vaccine had a favorable safety profile, was well tolerated, and demonstrated promising efficacy against clinical malaria, particularly when administered in a delayed third-dose regimen. The research, funded by various organizations, highlighted the potential of RH5.1/Matrix-M as a safe and highly immunogenic vaccine for African children, with ongoing monitoring of its efficacy. [Extracted from the article]

Researchers from the University of Lahore in Pakistan have conducted a study on rabies transmission dynamics, focusing on the impact of vaccination efficacy and incubation duration on infection patterns between dogs and humans. By utilizing advanced mathematical tools and machine learning techniques, such as artificial neural networks, the study aimed to provide a deeper understanding of rabies spread for more effective control strategies. The research, published in AIMS Mathematics, demonstrates the potential of these innovative approaches in epidemiological modeling. For more information, readers can access the full article through the provided link. [Extracted from the article]

A recent study conducted by the All India Institute of Medical Sciences (AIIMS) focused on the treatment practices for Subacute Sclerosing Panencephalitis (SSPE) among neurologists in India. The research highlighted the lack of defined treatment strategies for SSPE and the need for better management approaches. The study surveyed 298 neurologists, revealing varying preferences for disease-modifying strategies and symptomatic therapy, with a focus on personalized therapy for individual patients. The findings underscore the importance of prevention through vaccination and the urgent need for improved treatment strategies for SSPE patients in India. [Extracted from the article]

A study conducted by the University of Paris in Gabon found evidence of natural exposure to rabies in rural populations. The research revealed that some unvaccinated individuals in rural areas can be exposed to the virus and survive, developing a specific humoral response that can last for over 15 years. The study emphasizes the need for a national surveillance system for rabies in both humans and animals, as well as improved access to pre- and post-exposure prophylaxis. This research sheds light on the circulation of rabies in Gabon and the potential for non-lethal human exposure to the virus. [Extracted from the article]

A recent report from the National Institute for Viral Disease Control and Prevention in Beijing, China, discusses the development of mRNA rabies vaccines as a potential alternative to traditional vaccines. Rabies, primarily transmitted by dogs, has a high mortality rate, emphasizing the importance of post-exposure prophylaxis and vaccination. The research highlights the need for safe, cost-effective, and highly immunogenic vaccines to improve compliance and prevent rabies effectively. This study evaluates the potential of mRNA vaccines in replacing existing rabies vaccines, offering promising advancements in rabies prevention. [Extracted from the article]

A recent study conducted at the University of Putra Malaysia analyzed rabies epidemiology in Malaysia from 2015 to 2023, revealing challenges in controlling dog-mediated human rabies. The study found that Sarawak reported the highest proportion of rabies cases, with dogs comprising 89.35% of confirmed cases. The research emphasized the need for improved public health measures and surveillance to address the high fatality rate of human rabies cases in Sarawak. [Extracted from the article]

Researchers at Emory University conducted a study comparing the safety and immunogenicity of a novel rabies vaccine using a chimpanzee adenovirus vector with a licensed inactivated rabies vaccine in healthy adults. The study found that the novel vaccine was safe and tolerable but generated lower and less durable rabies antibody titers compared to the standard vaccine, possibly due to preexisting anti-vector immunity. The research was supported by the Division of Microbiology and Infectious Diseases and has been peer-reviewed. For more information, readers can refer to the original article published in Vaccine. [Extracted from the article]

A recent report from the Indian Institute of Technology Guwahati highlights the prevalence of dog-mediated rabies in India, despite available interventions. The case study of a 59-year-old man's death after a dog bite underscores the need for a comprehensive One Health approach to address rabies, including education, post-exposure prophylaxis, canine vaccines, responsible dog ownership, and collaboration across sectors. The research emphasizes the importance of effective communication and synergy among healthcare, veterinary, and public health sectors to enhance rabies prevention and control efforts in rural Northeast India. [Extracted from the article]

The article from TB & Outbreaks Week discusses research conducted at the University of Western Ontario on the risks associated with handling bats and the potential exposure to rabies virus. The study emphasizes the importance of bat handlers being vaccinated against rabies and regularly tested for rabies virus neutralizing antibodies to prevent unnecessary exposures. It also highlights the need for proper protective measures, such as using appropriate gloves, to avoid bites that could lead to exposure to lyssaviruses in bat saliva. The research underscores the significance of understanding viral transmission, preventing exposures, and responding effectively to bat bites to minimize the risks of this deadly zoonosis. [Extracted from the article]

A study conducted at Jilin Agricultural University in Changchun, People's Republic of China, focused on developing a vaccine against Marburg virus disease (MVD), a lethal viral hemorrhagic fever with no approved vaccine or therapy. The research involved using three recombinant rabies virus vector vaccines to induce neutralizing antibodies against different strains of Marburg virus in mice and humanized models. The study concluded that these vaccines show promise as candidates against various MARV strains, and a fully humanized neutralizing antibody against MARV was successfully isolated. [Extracted from the article]

A study conducted in Tanzania compared the effectiveness of annual team-based versus continuous community-based dog vaccination strategies to combat rabies. The community-based approach, which involved locally-stored vaccines managed by village leaders, achieved significantly higher and more consistent coverage than the team-based approach. This decentralized delivery method could be crucial in achieving national rabies elimination goals in sub-Saharan African countries and potentially reducing human rabies deaths globally by 2030. The study has not yet undergone peer review. [Extracted from the article]

A study conducted in the West Shewa Zone of Oromia, Ethiopia, aimed to assess the knowledge, attitude, and practices related to rabies among the community from 2017 to 2021. The results showed that the community had varying levels of knowledge, attitude, and practice scores regarding rabies, with factors such as dog ownership, media exposure, and previous exposure influencing these scores. The study also highlighted the economic impact of rabies in the area, with a higher number of human cases compared to animal cases, resulting in significant costs. Effective control measures, including vaccination and awareness campaigns, were recommended to address the lack of awareness and prevent the spread of rabies in the region. [Extracted from the article]

A recent report from Fattouma Bourguiba University Hospital highlights the importance of a One-Health approach in addressing rabies in Tunisia. The study analyzed human exposures to animals in the central region of Tunisia from 2019 to 2022, revealing a high incidence of animal bites, particularly from dogs. The research emphasizes the need for preventive strategies, such as mass dog vaccination programs, and public awareness campaigns to reduce the risk of rabies transmission, especially among children and adolescents. [Extracted from the article]

A study conducted by researchers at Nong Lam University in Vietnam focused on estimating the costs of rabies control measures in Long An province in 2022. The study found that the total annual costs of rabies control were estimated to be around USD 2.67 to 2.68 million, with the majority of expenses being paid by the private sector rather than the public sector. The research concluded that mass vaccination for animals is more cost-effective than post-exposure treatment (PET) to prevent human deaths from rabies. [Extracted from the article]

A recent study by the Canadian Food Inspection Agency highlights the emerging public health issue of rabies in cats. While human rabies cases are mainly linked to infected domestic dogs, cats can also transmit the virus. The research emphasizes the importance of educating the public about rabies in cats and the necessity of routine vaccination to mitigate risks to public health, agriculture, and conservation biology. The study underscores the need for a One Health approach to address the global elimination of rabies in both dogs and cats. [Extracted from the article]

A study conducted in Israel by Veterinary Services examined the effectiveness of rabies vaccination in sheep and goats, with and without booster doses. Results showed that a high percentage of animals had sufficient rabies antibodies after the initial vaccination, and booster doses helped maintain antibody levels in some cases. Variations in immune responses between species suggest the need for further research to tailor vaccination protocols for different animals. The study highlights the importance of vaccination in preventing rabies in farm animals. [Extracted from the article]

Researchers from the Guangdong Provincial Institute of Public Health conducted an online survey to examine the establishment and operation of rabies post-exposure prophylaxis clinics in Guangdong province. The survey found that there were significant differences in functional area arrangement, equipment allocation, personnel allocation, service, and management among clinics in various medical institutions. The study concluded that standardized construction of rabies clinics, especially at the grassroots level, needs to be strengthened in Guangdong province. [Extracted from the article]

A study conducted in the Serengeti district of Tanzania analyzed the impact of spatial heterogeneity in dog vaccination coverage on the effectiveness of rabies control. The research found that higher local vaccination coverage correlated with lower dog rabies incidence, but incidence was also influenced by prior incidence rates in the district. By reducing spatial variation in vaccination coverage, outbreaks were minimized, highlighting the importance of fine-scale monitoring in vaccination programs. The study emphasizes the need for tailored vaccination strategies to effectively manage infectious diseases like rabies. [Extracted from the article]

Researchers at Nankai University have developed a new rabies virus vaccine candidate using a self-assembling nanoparticle engineered from the ferritinophagy complex. This vaccine induces potent immune responses and provides protection against rabies virus in mice after a single dose. The universal ferritin-based antigen conjugating strategy used in this study shows promise for developing vaccines against various pathogens and diseases. The research was published in Nature Communications and offers insights into the potential of ferritin-based vaccines for enhancing antigen immunogenicity and safety profiles. [Extracted from the article]

This document is a patent for a rabies vaccine composition that includes an adjuvant called PIKA. The patent describes the specific amounts of PIKA adjuvant, inactivated purified rabies virus (IPRV), and human serum albumin (HSA) that are used in the vaccine. The patent also provides instructions for administering the vaccine to both humans and animals. The vaccine can be given as a treatment for rabies or as a preventive measure. The patent includes various embodiments and dosage regimens for different scenarios. For more information, refer to the patent document. [Extracted from the article]

A recent study conducted by the Department of Pathobiology highlights the ongoing challenges faced by Ghana in controlling and preventing rabies. The disease is a significant public health issue in rural communities with limited access to healthcare and veterinary services. The study examines the interventions, challenges, and opportunities related to rabies control in Ghana, including dog vaccination efforts and One Health strategies. The research emphasizes the importance of adopting One Health principles to eliminate rabies in Ghana by 2030 and suggests that addressing challenges such as low vaccination coverage, weak surveillance, and inadequate coordination across sectors can strengthen rabies control programs in the country. [Extracted from the article]

A recent study conducted by the National Institute for Viral Disease Control and Prevention in China examined the epidemiological characteristics of human rabies cases reported from 2006 to 2022. The study found that rabies remains a significant public health threat in China, with incidence rates consistently above the national average. The research highlighted the importance of implementing effective prevention and control measures, including a robust dog management system, the development of animal vaccines, and improved post-exposure prophylaxis. The study concluded that various government measures have played a key role in reducing the incidence of rabies, but further efforts are needed to prevent the resurgence of epidemics and halt the spread of the virus among host animals. [Extracted from the article]

A recent study conducted in Cambodia has shown that short-duration, large-scale canine rabies vaccination campaigns can effectively achieve high vaccination coverage in urban areas. Over a period of 10 days, 120 vaccination teams traveled door-to-door to administer rabies vaccines to dogs and cats. The campaign successfully vaccinated 74,983 dogs and 2,145 cats, with a mean vaccination rate of 62.5 dogs per team per day. Post-vaccination surveys estimated a mean vaccination coverage of 70.7% in owned dogs. These findings provide valuable insights for the planning and refinement of future rabies control strategies in Cambodia. [Extracted from the article]

A recent study conducted by researchers at the University of California has provided new insights into the structural heterogeneity of the rabies virus. The study utilized cryogenic electron tomography and microscopy to determine the three-dimensional structure of the wild-type rabies virus. The researchers found that the virus exhibits a high level of structural heterogeneity, particularly in the glycoprotein trimer-decorated envelope and the nucleocapsid composed of RNA, nucleoprotein, and matrix protein. These findings suggest different mechanisms of viral assembly compared to other rhabdoviruses. This research contributes to our understanding of the rabies virus and may have implications for the development of viral vaccines. [Extracted from the article]

A study conducted by researchers at Washington State University examined the impact of performance-based pay on dog vaccination rates in Tanzania to prevent human rabies. The study found that a mixed payment system, combining fixed payment and pay-for-performance, increased dog vaccinations by 16% compared to fixed payment alone. Additionally, each 10% increase in per-dog payment raised vaccinations by 0.4%. The findings suggest that pay-for-performance can improve the effectiveness of rural development projects, such as mass immunization events. [Extracted from the article]

A study conducted by the National Agricultural Technology Institute in Balcarce, Argentina, focused on the rabies virus and its control through mass animal vaccination campaigns. The study aimed to test the large-scale expression of the rabies N protein in a prokaryotic system. The recombinant N protein was successfully expressed and purified, and it was able to induce the production of specific antibodies in a mouse immunization assay. These findings suggest that the recombinant N protein could be used as an antigen for the development of a subunit vaccine or for diagnostic purposes. [Extracted from the article]

A recent report from the University of Kinshasa discusses the factors associated with the rabies vaccination status of dogs in households in Beni City, Democratic Republic of Congo. The study found that the rabies vaccination coverage in Beni was only 26%, indicating a low level of protection against the disease. Factors such as the education level of the household head, the number of dogs in the household, the age of the dogs, and the type of dog breeding were found to be associated with the vaccination status. The researchers recommend mass vaccination campaigns targeting dog owners with low education levels, those raising multiple dogs, and dogs less than 12 months old. [Extracted from the article]

A recent study conducted at the State University of New York - Stony Brook University examined the spatial clustering of rabies cases in different animal species in New Jersey from 1989 to 2023. The researchers analyzed data on rabies cases in raccoons, skunks, bats, cats, foxes, and groundhogs, and used statistical methods to identify global and local spatial clusters of rabies. The study found significant spatial clustering of rabies in raccoons, foxes, and groundhogs in specific regions of New Jersey. These findings could inform targeted oral rabies vaccination programs in high-risk counties, reducing the risk of rabies exposure for domestic animals and humans. [Extracted from the article]

A patent application has been submitted for a synergistic phytoextract formulation that has anti-inflammatory properties. The formulation includes phytoextracts from Elettaria cardamomum, Salvia rosmarinus, and piperine extract. The active molecule 1,8 Cineol found in the phytoextracts has muscle relaxant, anti-inflammatory, and analgesic effects. The formulation is intended for oral administration and may have anti-viral and anti-bacterial properties. The patent application aims to develop a natural herbal formulation for COVID-19 patients to aid in their recovery without harmful side effects. [Extracted from the article]

A recent study conducted by researchers at the Hangzhou Center for Disease Control and Prevention in China examined the factors that influence the persistence of virus neutralizing antibodies (VNA) in individuals who receive post-exposure rabies vaccines. The study found that the 2-1-1 vaccination schedule was more effective than the 5-dose course for primary vaccination. Additionally, the use of residual rabies immunoglobulin for distal intramuscular injection was not recommended. The study also established prediction models to determine the appropriate timing for booster vaccinations based on VNA titres. The findings of this study provide valuable insights for improving rabies vaccination strategies. [Extracted from the article]

A recent study conducted by researchers at Thomas Jefferson University Sidney Kimmel Medical College has shown promising results for a potential vaccine against Lassa fever. Lassa fever is a severe hemorrhagic disease caused by the Lassa fever virus (LASV) and is prevalent in West Africa. Currently, there are no FDA-licensed vaccines or specific therapeutics available for Lassa fever. The study tested a deactivated rabies virus-based vaccine called LASSARAB on nonhuman primates, which developed strong immune responses to LASV-GPC and survived when challenged with the virus. The researchers concluded that LASSARAB is a promising candidate for further development. [Extracted from the article]

A research study conducted by the Oswaldo Cruz Institute (FIOCRUZ) in Brazil has examined the impact of rabies on herbivores, particularly cattle, horses, and goats. The study highlights the economic burden and health risks associated with herbivorous rabies, emphasizing the need for effective strategies to control the disease. Vaccination campaigns, public awareness programs, and enhanced surveillance systems are recommended as key measures to mitigate the impact of rabies on livestock and public health. The study concludes that investing in rabies vaccination and control measures not only protects livestock but also reduces human cases and strengthens the sustainability of the livestock industry. [Extracted from the article]